Everyone nods at the pipeline review.
The deals died months ago.
That's B2B's politest fiction: a forecast full of deals nobody has spoken to since last quarter, reviewed weekly, questioned never. We come from insurance — high-volume, quota-driven selling with our own money on the line — and the machine we built there, from a $227 first commission to a ~$1.3M-a-year recurring book, fixes the same leaks your pipeline has. Because the leaks are the same wherever humans sell.